Guerrero-Vargas, J.M.; Suarez-Garcia, D.A.; Leal, A.F.; Diaz-Ariza, I.L.; Pérez-Pérez, L.D.; Espejo-Mojica, A.J.; Alméciga-DÃaz, C.J.
Evaluation of the PP6D5 Polymer as a Novel Non-Viral Vector in the Development of a CRISPR/nCas9-Based Gene Therapy for Tay–Sachs Disease. Pharmaceutics 2025, 17, 628.
https://doi.org/10.3390/pharmaceutics17050628
AMA Style
Guerrero-Vargas JM, Suarez-Garcia DA, Leal AF, Diaz-Ariza IL, Pérez-Pérez LD, Espejo-Mojica AJ, Alméciga-DÃaz CJ.
Evaluation of the PP6D5 Polymer as a Novel Non-Viral Vector in the Development of a CRISPR/nCas9-Based Gene Therapy for Tay–Sachs Disease. Pharmaceutics. 2025; 17(5):628.
https://doi.org/10.3390/pharmaceutics17050628
Chicago/Turabian Style
Guerrero-Vargas, Jacky M., Diego A. Suarez-Garcia, Andrés F. Leal, Ivonne L. Diaz-Ariza, León D. Pérez-Pérez, Angela J. Espejo-Mojica, and Carlos J. Alméciga-DÃaz.
2025. "Evaluation of the PP6D5 Polymer as a Novel Non-Viral Vector in the Development of a CRISPR/nCas9-Based Gene Therapy for Tay–Sachs Disease" Pharmaceutics 17, no. 5: 628.
https://doi.org/10.3390/pharmaceutics17050628
APA Style
Guerrero-Vargas, J. M., Suarez-Garcia, D. A., Leal, A. F., Diaz-Ariza, I. L., Pérez-Pérez, L. D., Espejo-Mojica, A. J., & Alméciga-DÃaz, C. J.
(2025). Evaluation of the PP6D5 Polymer as a Novel Non-Viral Vector in the Development of a CRISPR/nCas9-Based Gene Therapy for Tay–Sachs Disease. Pharmaceutics, 17(5), 628.
https://doi.org/10.3390/pharmaceutics17050628
